Vaccine News and Research

Latest Vaccine News and Research

African genome research given impetus

Millions of victims in Africa, die each year from preventable diseases like tuberculosis and malaria and researchers say only a relatively small proportion of money is spent on developing vaccines, much more is spent on drugs aimed at tackling diseases more prevalent among rich, Western consumers.

21 Mar 2005

New information on TB available online

A range of new information on TB including top facts and a handy Q&A will be available at the click of a button when it goes live on www.immunisation.nhs.uk tomorrow - ahead of World Stop TB Day.

21 Mar 2005

Invasive pneumonia and antibiotic resistance decreased after childhood streptococcus pneumoniae vaccine introduced

The problem of increasing antibiotic resistance in cases of Streptococcus pneumoniae, a major cause of pneumonia, meningitis and sepsis, was dramatically reversed following the licensing and use of a new conjugate vaccine for young children in February 2000, according to research conducted at Emory University, the Atlanta Veterans Affairs Medical Center, the Centers for Disease Control and Prevention, and the Georgia Division of Public Health.

21 Mar 2005

Genetically modified plants are to be used to fight against HIV, tuberculosis, diabetes and rabies

Genetically modified (GM) plants are to be used to grow vaccines for use in the worldwide fight against HIV, tuberculosis, diabetes and rabies thanks to a grant of 12 million euros from the EU’s Sixth Framework Programme (FP6).

21 Mar 2005

Key target for Foot-and-Mouth drug revealed

A complete picture of Foot-and-Mouth Disease's key replication enzyme could lead to the development of new drugs to control the disease without recourse to vaccination or slaughter, scientists report today.

21 Mar 2005

Wyeth responds to patent lawsuit ruling

Wyeth responded to the ruling today by the U.S. Court of Appeals for the Federal Circuit in the case of Israel Bio-Engineering Project v. Amgen, Inc.

16 Mar 2005

Risky surgery not always necessary to treat cervical disease

Revolutionary advancements in the treatment options for diseases associated with human papillomavirus (HPV) now include nonsurgical options such as chemoprevention and vaccines. A review of these methods is published in the latest issue of the International Journal of Gynecological Cancer.

16 Mar 2005

Vaccine for whooping cough in teens

The U.S. Food and Drug Administration (FDA) is recommending the development of a vaccine to prevent the occurrence of pertussis (Whooping Cough) in adolescents.

15 Mar 2005

Timing is everything when it comes to killing prostate cancer cells

"The window of opportunity is narrow for vaccination, designed to reinvigorate the immune system's attack on cancer cells, and it occurs right after hormonal therapy begins to wipe out the tumor and immune cells outnumber cancerous ones," according to Charles Drake, M.D., Ph.D.

15 Mar 2005

ID Biomedical pursues accelerated approval of influenza vaccine

ID Biomedical Corporation announced today that it has been advised by the United States Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) that the Company's injectable influenza vaccine is eligible for accelerated approval and priority review mechanisms, allowing possible licensure of the vaccine in time to manufacture product for the 2006/07 season.

15 Mar 2005

£800,000 to boost research into fighting viruses

A team of University of Glasgow scientists have received a grant of £800,000 from the Wellcome Trust to research a mechanism that blocks a critical step in the replication cycle of retroviruses. In the long term, the research could lead to the design of new therapeutic strategies or drugs against retroviruses, which cause diseases such as AIDS and certain leukemias.

14 Mar 2005

New H5N1 avian influenza vaccine

Merial today announced the introduction of a new inactivated vaccine, GALLIMUNE Flu H5N9, developed and shown to be effective specifically for use against the highly pathogenic avian influenza virus H5N1 that has caused devastating economic losses in the poultry industry in Asia, and which has been linked to the deaths of over 29 humans.

14 Mar 2005

China trials new HIV vaccine on humans

China which has 840,000 people with HIV, a conservative estimate say experts, will carry out the very first trials of a new virus on human guinea pigs.

13 Mar 2005

Openness and communication between experts and the public is key to winning the war over MMR

In 1998, MMR vaccinations in the United Kingdom reached 92% of its targets. Yet by 2002, after claims of a possible relation between MMR and autism, the United Kingdom lost considerable ground. One of the lowest levels of coverage of MMR is now found in London, at around 75%.

13 Mar 2005

New flu vaccine for kids hits the market

A new pediatric influenza vaccine that contains no preservatives - the only influenza vaccine approved for use in children 6 to 35 months of age - has been produced by the sanofi-aventis Group, in time for the 2005-2006 influenza season.

10 Mar 2005

Birdflu vaccine successful on monkeys

A bird flu vaccine for humans could be only months away since the success of a vaccine on monkeys in Vietnam, researchers hope to have a vaccine ready for testing in humans later this year.

10 Mar 2005

U.S. children undervaccinated

Approximately one-third of U.S. children were undervaccinated for more than six months and one-fourth experienced delays in receiving many of the recommended vaccinations during their first 24 months of life, according to a study in the current issue of JAMA.

9 Mar 2005